Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1999 1
2000 1
2002 1
2003 1
2004 1
2005 2
2006 1
2007 1
2009 2
2010 1
2011 2
2012 3
2013 1
2014 3
2015 3
2016 2
2019 2
2020 5
2021 4
2022 5
2023 5
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Reply to Gaskell et al.
Holzman SB, Perry A, Keh C, Salcedo K, Narita M, Ahmed A, Katz D, Krueger A, Shah M. Holzman SB, et al. Among authors: keh c. Clin Infect Dis. 2022 Nov 14;75(10):1864. doi: 10.1093/cid/ciac583. Clin Infect Dis. 2022. PMID: 35869850 No abstract available.
Comparison of Tuberculin Skin Testing and Interferon-γ Release Assays in Predicting Tuberculosis Disease.
Ayers T, Hill AN, Raykin J, Mohanty S, Belknap RW, Brostrom R, Khurana R, Lauzardo M, Miller TL, Narita M, Pettit AC, Pyan A, Salcedo KL, Polony A, Flood J; CDC Tuberculosis Epidemiologic Studies Consortium. Ayers T, et al. JAMA Netw Open. 2024 Apr 1;7(4):e244769. doi: 10.1001/jamanetworkopen.2024.4769. JAMA Netw Open. 2024. PMID: 38568690 Free PMC article.
Implementation of Bedaquiline, Pretomanid, and Linezolid in the United States: Experience Using a Novel All-Oral Treatment Regimen for Treatment of Rifampin-Resistant or Rifampin-Intolerant Tuberculosis Disease.
Haley CA, Schechter MC, Ashkin D, Peloquin CA, Peter Cegielski J, Andrino BB, Burgos M, Caloia LA, Chen L, Colon-Semidey A, DeSilva MB, Dhanireddy S, Dorman SE, Dworkin FF, Hammond-Epstein H, Easton AV, Gaensbauer JT, Ghassemieh B, Gomez ME, Horne D, Jasuja S, Jones BA, Kaplan LJ, Khan AE, Kracen E, Labuda S, Landers KM, Lardizabal AA, Lasley MT, Letzer DM, Lopes VK, Lubelchek RJ, Patricia Macias C, Mihalyov A, Misch EA, Murray JA, Narita M, Nilsen DM, Ninneman MJ, Ogawa L, Oladele A, Overman M, Ray SM, Ritger KA, Rowlinson MC, Sabuwala N, Schiller TM, Schwartz LE, Spitters C, Thomson DB, Tresgallo RR, Valois P, Goswami ND; BPaL Implementation Group. Haley CA, et al. Clin Infect Dis. 2023 Oct 5;77(7):1053-1062. doi: 10.1093/cid/ciad312. Clin Infect Dis. 2023. PMID: 37249079 Free PMC article.
Epithelioid angiosarcoma in a perforated appendix.
Tan NJH, Keh CHL, Lui SA, Thamboo TP. Tan NJH, et al. Among authors: keh chl. Pathology. 2020 Feb;52(2):276-278. doi: 10.1016/j.pathol.2019.09.019. Epub 2019 Dec 26. Pathology. 2020. PMID: 31883674 No abstract available.
Pilonidal Abscess Associated With Primary Actinomycosis.
Oh HB, Abdul Malik MH, Keh CH. Oh HB, et al. Among authors: keh ch. Ann Coloproctol. 2015 Dec;31(6):243-5. doi: 10.3393/ac.2015.31.6.243. Epub 2015 Dec 31. Ann Coloproctol. 2015. PMID: 26817020 Free PMC article.
Highlighting the characteristics of TB disease in older people.
Louie JK, Keh C, Agraz-Lara R, Phillips A, Graves S. Louie JK, et al. Among authors: keh c. Int J Tuberc Lung Dis. 2023 Jun 1;27(6):478-480. doi: 10.5588/ijtld.22.0597. Int J Tuberc Lung Dis. 2023. PMID: 37231601 No abstract available.
48 results